Pharmacogenomics: Leveraging Capacity to Expand Molecular Laboratory Capabilities
Who should attend?
- Clinical laboratory directors
- Laboratory managers
- Clinical pathologists
- Healthcare executives
- Academic medical centers
- Public health laboratories
- Laboratory technicians
- Anyone involved in clinical laboratory testing
- Learn about the importance of genetics and laboratory services in medication management
- Be able to describe molecular genetic assay requirements for pharmacogenomics (PGx) testing
- Understand the stages of PGx testing implementation as it relates to individual laboratory maturity
- Learn the strategic actions to take to expand into PGx
- Be able to define which stage your laboratory is currently in and assess for potential expansion
About this webinar
Presenter: Jeffrey A. Shaman, PhD, MS
Pharmacogenomics (PGx) has immense potential in the routine clinical testing space. However, there are many considerations to PGx adoption and scalability within the laboratory. Clinical laboratory leaders are unaware of their laboratory’s readiness, the stages of PGx implementation maturity, and the strategic steps they should take to expand into PGx.
In this Dark Daily webinar with live Q&A, Jeff Shaman, PhD, MS, Chief Science Officer of Coriell Life Sciences will discuss why pharmacogenomics matters and how the COVID health crisis has created unprecedented capacity and acceptance for PGx in laboratory testing.
Up-and-coming and seasoned lab leaders will learn how laboratory technology, science, implementation models, and economic proof points have all achieved deployable maturity for PGx labs. Most importantly, we will define the stages of PGx laboratory implementation maturity and key success points for expanding your laboratory’s PGx testing capacity.